Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Richard Boehme"'
Publikováno v:
Computers and Education: Artificial Intelligence, Vol 6, Iss , Pp 100233- (2024)
In Germany (similar to other countries), 30 % of students demonstrate insufficient spelling skills at the end of primary school – partly owing to the challenge for teachers to manage a variety of students' learning needs. Digital tools using Machin
Externí odkaz:
https://doaj.org/article/c01f97c834f84ff2a1d25caf86faa379
Publikováno v:
HIV Therapy. 4:293-303
HIV enters cells via the CD4 receptor and a coreceptor, generally CCR5 or CXCR4. The specific coreceptor used by a patient’s virus is referred to as its tropism. Tropism testing is necessary prior to treatment with CCR5 antagonist medication to rul
Autor:
Simona Urbani, Carlo Ferrari, Richard Boehme, Massimo Pilli, Antonio Bertoletti, A. Cavalli, Ruggero Panebianco, Carolina Boni, Franco Fiaccadori, Paola Scognamiglio, Amalia Penna
Publikováno v:
Scopus-Elsevier
High viral and/or antigen load may be an important cause of the T cell hyporesponsiveness to hepatitis B virus (HBV) antigens that is often observed in patients with chronic HBV infection. Reduction of viral and antigen load by lamivudine treatment r
Autor:
Frank Nemeth, Richard A. Beekman, Sean Derrick, Kelly Tanaka, Brian Rumberg, Peter W. Dibble, Ken M. Wong, Richard Boehme
Publikováno v:
Tetrahedron. 52:7679-7690
We have examined a series of 1,3-dihydro-1-isobenzofuranamines that exist in an imine/hemiaminal ring-chain tautomerism. The tautomeric free energies are rationalized in terms of electronic and steric effects. A series of compounds bearing substituen
Autor:
Martin A. Nowak, Andrew M. Hill, Hugh McDade, Richard Boehme, Sebastian Bonhoeffer, Howard C. Thomas
Publikováno v:
Proceedings of the National Academy of Sciences. 93:4398-4402
Treatment of chronic hepatitis B virus (HBV) infections with the reverse transcriptase inhibitor lamivudine leads to a rapid decline in plasma viremia and provides estimates for crucial kinetic constants of HBV replication. We find that in persistent
Publikováno v:
Antimicrobial Agents and Chemotherapy. 36:1688-1694
(-)-2'-Deoxy-3'-thiacytidine (3TC) is a selective inhibitor of human immunodeficiency virus replication in vitro (J. A. V. Coates, N. Cammack, H. J. Jenkinson, A. J. Jowett, M. I. Jowett, B. A. Pearson, C. R. Penn, P. L. Rouse, K. C. Viner, and J. M.
Autor:
Richard Boehme
Publikováno v:
Careers in Food Science: From Undergraduate to Professional ISBN: 9780387773902
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4fa7a251bdc6e4e3ef494553f57dde3
https://doi.org/10.1007/978-0-387-77391-9_19
https://doi.org/10.1007/978-0-387-77391-9_19
Autor:
Richard Boehme, Nathaniel A. Brown
Publikováno v:
Hepatitis Prevention and Treatment ISBN: 9783034896177
Hepatitis B virus (HBV) infection causes both acute and chronic hepatitis and is a major global health problem. Worldwide, it is estimated that 50 million new HBV infections occur annually, and approximately 350-400 million people are chronically HBV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29d7fea54736e589bb5673ea283e7e27
https://doi.org/10.1007/978-3-0348-7903-3_7
https://doi.org/10.1007/978-3-0348-7903-3_7
Autor:
Ching-Lung Lai, Jules L. Dienstag, Mark Atkins, Nancy Leung, Christine M. Hunt, Mary Woessner, Lynn D. Condreay, Richard Boehme, Eugene R. Schiff, Nathaniel A. Brown
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 36(6)
YMDD variants of hepatitis B virus (HBV) emerge in some patients with chronic hepatitis B who receive lamivudine. YMDD variants were examined in 794 patients in 4 controlled studies of 1 year's duration. The long-term effects of YMDD variants were ex
Autor:
Carolina Boni, Franco Fiaccadori, Graham S. Ogg, Amalia Penna, Antonio Bertoletti, A. Cavalli, Cristina Cavallo, Richard Boehme, Simona Urbani, Massimo Pilli, Ruggero Panebianco, Carlo Ferrari
Publikováno v:
Hepatology (Baltimore, Md.). 33(4)
The hepatitis B virus (HBV) cytotoxic T lymphocyte (CTL) response in patients with chronic HBV infection is generally weak or totally undetectable. This inability to mount protective CTL responses is believed to be a crucial determinant of viral pers